BCS
Barclays PLC
$28.28
▲ 1.8%Updated Today 12:11 PM ET
BCS at a glance — five pillars scored 0–100 from real filed financials.
Overall: Neutral · 56/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 54.9% over the last 12 months
Market Cap
$89.46B
P/E
6.37x
Forward P/E (est.)
4.55x
ROE
14.4%
Revenue Growth
—
EPS Growth
48.3%
Profit Margin
—
FCF Yield
—
Debt / Equity
3.55x
ROIC
—
Interest Coverage
—
Current Ratio
—
Dividend Yield
1.6%
Implied Growth (rev. DCF)
—
Rating Score
56/100
Barclays PLC (BCS) is a large-cap company in the Banking industry, part of the Financials sector of the S&P 500, with a market value around $89.46B.
Our model rates BCS Neutral (56/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what BCS's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. BCS trades near $28.28, above its 50-day average ($24.60) and 200-day average ($23.46). Price above both averages, with the shorter one above the longer, is the textbook definition of an uptrend — momentum favours buyers.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 76 it is overbought — the recent rally is stretched and can cool off.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. BCS's is $0.63 (~2.2% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month BCS found buyers near $23.64 (support) and sellers near $28.29 (resistance); its 52-week range is $18.11–$28.29. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.4× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
Where BCS sits versus its Financials sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 95 Financials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How BCS stacks up against its Financials peers — valuation, profitability, and growth versus the sector median.
In the Financials sector (181 S&P 500 companies), BCS ranks #64 of 181 by our overall rating. It trades at a discount versus the sector on earnings (6.4x P/E vs. 15.3x median) with a higher return on equity (14.4% vs. 13.6%).
P/E vs sector
6.4x
median 15.3x
ROE vs sector
14.4%
median 13.6%
Growth vs sector
—
median 15.5%
Sector rank
#64
of 181 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Financials companies by sub-industry and size. Sector median is across all 181 S&P 500 names in the sector. Educational, not a recommendation.
The case for BCS:
- As an established S&P 500 member in Financials, it brings scale and a long operating history.
The case against BCS:
- Elevated leverage (debt/equity 3.5x) adds financial risk.
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Balance-sheet risk — debt/equity of 3.5x magnifies the impact of higher rates or weaker earnings.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: Barclays PLC is a large-cap financials business growing at a mature pace, with modest profitability, and a heavier debt load to watch. It trades at 6.4x earnings, which our model scores Neutral (56/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
BCS — frequently asked questions
Is BCS a good stock to buy?
We don't give buy or sell advice. Our model rates Barclays PLC Neutral (56/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is BCS's rating on The Stocks School?
Barclays PLC currently scores 56/100 (Neutral) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does BCS's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Barclays PLC's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for BCS calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this BCS analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell BCS. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.